Postpartum Hemorrhage Treatment Device

Postpartum Hemorrhage Treatment Device Market Outlook

The global postpartum hemorrhage treatment device market is poised to reach approximately USD 2.5 billion by 2035, growing at a CAGR of around 6.8% during the forecast period of 2025 to 2035. The increasing incidence of postpartum hemorrhage, attributed to rising rates of cesarean deliveries and maternal health complications, is a significant factor driving this market's growth. Additionally, advancements in medical technologies and the introduction of innovative devices that enhance the effectiveness of postpartum hemorrhage management are further supporting market expansion. The growing awareness among healthcare professionals regarding the importance of timely intervention and the provision of adequate training for the use of these devices are also contributing positively. Moreover, the strategic initiatives by governments and health organizations to improve maternal healthcare systems globally are expected to bolster the adoption of these treatment devices in various healthcare settings.

Growth Factor of the Market

The postpartum hemorrhage treatment device market is significantly driven by several growth factors, including the escalating prevalence of maternal health issues and the increasing focus on reducing maternal mortality rates. With postpartum hemorrhage being a leading cause of maternal death, the demand for effective treatment devices is becoming more pronounced, prompting investments in research and development. Furthermore, the rising awareness about the availability of advanced treatment options among healthcare providers and patients contributes to market growth. The integration of technology in medical devices is enhancing their efficacy and usability, making it easier for healthcare professionals to manage postpartum hemorrhage. Additionally, the growing prevalence of high-risk pregnancies necessitates improved healthcare facilities and equipment, leading to an upsurge in the demand for postpartum hemorrhage treatment devices. The enhancement of healthcare infrastructure in developing regions further supports the expansion of this market.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 6.8% from 2025 to 2035.
• North America dominates the market share, accounting for over 40% of the global market.
• Innovative technologies such as balloon tamponade are gaining traction in the treatment of postpartum hemorrhage.
• Increased government initiatives to improve maternal healthcare are driving market growth.
• Hospitals remain the largest application segment, contributing significantly to market revenues.

By Product Type

Uterine Balloon Tamponade:

Uterine balloon tamponade is one of the leading product types in the postpartum hemorrhage treatment device market. This device is designed to apply pressure to the uterine walls, effectively controlling excessive bleeding. The rising incidence of uterine atony, which is often the primary cause of postpartum hemorrhage, drives the demand for this product. Its ease of use and non-invasive nature make it a preferred choice among healthcare providers. The advancement in materials and technology has also improved the efficacy of these devices, leading to better patient outcomes. In many cases, uterine balloon tamponade can be used as a first-line treatment, reducing the need for surgical interventions and thus minimizing recovery time for patients. Therefore, this product type continues to be a significant contributor to the overall market growth.

Non-Pneumatic Anti-Shock Garments:

Non-pneumatic anti-shock garments represent another critical segment in the postpartum hemorrhage treatment device market. These garments are designed to control bleeding by applying external pressure to the abdomen, which helps to stabilize the patient until further medical treatment can be administered. Their quick application and effectiveness in emergency situations make them invaluable in both hospital settings and pre-hospital scenarios. As awareness of the importance of timely intervention in managing postpartum hemorrhage grows, the demand for these garments is on the rise. Furthermore, advancements in design and material have enhanced their comfort and usability, making them popular among healthcare providers. This segment is projected to witness substantial growth as more healthcare facilities adopt these innovative solutions for effective patient management.

Hemostatic Agents:

Hemostatic agents play a crucial role in managing postpartum hemorrhage by promoting blood clotting and reducing bleeding. This product type includes various agents such as topical hemostatic powders and gels that are used in conjunction with other treatment devices. The increasing variety of hemostatic agents available in the market allows healthcare providers to choose the most suitable option based on the specific needs of the patient. The growing focus on blood conservation and the effective management of blood loss during childbirth is driving the demand for these agents. Furthermore, the rising number of surgeries and interventions during childbirth, along with the growing number of women opting for cesarean sections, is contributing to the increased popularity of hemostatic agents as essential components of postpartum hemorrhage management.

Suturing Devices:

Suturing devices are instrumental in the management of postpartum hemorrhage, especially in cases where lacerations or tears occur during delivery. These devices facilitate the quick and efficient suturing of wounds, thereby reducing the risk of excessive bleeding. The evolution of suturing technology, including the development of advanced sutures and devices that ensure precision and ease of use, has significantly impacted this segment. Additionally, the growing focus on minimizing maternal morbidity and enhancing post-operative recovery times is driving the demand for these devices. Healthcare facilities are increasingly recognizing the importance of having suturing devices readily available as part of their emergency obstetric care protocols, thereby contributing to the overall growth of the postpartum hemorrhage treatment device market.

Others:

This segment encompasses various additional products utilized in the treatment of postpartum hemorrhage, including medical instruments and devices designed for specific interventions. These products complement the primary treatment devices and are essential for comprehensive care management. As the field of obstetrics continues to innovate, new devices and instruments are constantly being developed to address the growing challenges associated with postpartum hemorrhage. The introduction of these novel products is expected to significantly enhance the effectiveness of treatment protocols and improve patient outcomes. As healthcare professionals become more adept at utilizing these diverse tools, the 'Others' segment is projected to witness notable growth, providing supplementary support to mainstream treatment devices.

By Application

Hospitals:

Hospitals represent the largest application segment in the postpartum hemorrhage treatment device market, providing comprehensive care for women experiencing complications during childbirth. The advanced infrastructure and availability of specialized medical personnel enable hospitals to manage severe cases of postpartum hemorrhage efficiently. Hospitals are equipped with the necessary devices and technologies to intervene swiftly, which is critical in saving the lives of mothers facing this potentially life-threatening condition. The rising number of childbirths in hospitals and the increasing awareness of the importance of adequate maternal care contribute to the growth of this segment. Furthermore, hospitals are continuously evolving their protocols and procedures to include the latest advancements in postpartum hemorrhage management, further driving the demand for treatment devices in this setting.

Maternity Centers:

Maternity centers are becoming increasingly prominent in the postpartum hemorrhage treatment device market, offering specialized care for pregnant women and new mothers. These centers provide a more personalized and supportive environment compared to traditional hospitals and focus on the holistic well-being of mothers and babies. As more women opt for maternity centers for their childbirth experience, the demand for postpartum hemorrhage treatment devices in these settings is expected to rise. The emphasis on patient-centered care, alongside the availability of trained professionals, allows maternity centers to effectively manage complications such as postpartum hemorrhage. Moreover, the growing trend of home-like birthing experiences is propelling the establishment of maternity centers, which is likely to have a positive impact on the uptake of treatment devices within this segment.

Homecare Settings:

Homecare settings are gradually gaining traction in the postpartum hemorrhage treatment device market as more mothers seek postnatal care in the comfort of their homes. With advancements in telemedicine and remote monitoring, healthcare providers can now offer efficient management of postpartum hemorrhage even outside traditional healthcare facilities. The growing recognition of the importance of postnatal care and the desire for personalized recovery experiences are driving the demand for homecare solutions. Additionally, devices designed for home use are being developed to ensure that mothers can manage their health effectively during the postpartum period. As homecare becomes an integral part of maternal healthcare, the market for postpartum hemorrhage treatment devices in this segment is expected to expand significantly.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies play a vital role in the distribution of postpartum hemorrhage treatment devices, serving as a primary procurement source for healthcare institutions. These pharmacies ensure that hospitals are well-stocked with essential medical devices and supplies required for managing postpartum complications. The convenience of having immediate access to these devices in hospitals facilitates timely intervention, which is crucial in cases of postpartum hemorrhage. As hospitals increasingly recognize the importance of being prepared for obstetric emergencies, the demand for postpartum hemorrhage treatment devices through hospital pharmacies is likely to grow. Additionally, the integration of technology in inventory management systems within hospital pharmacies improves the efficiency of device availability, enhancing overall patient care.

Retail Pharmacies:

Retail pharmacies are emerging as significant players in the postpartum hemorrhage treatment device market, catering to the needs of mothers who prefer to manage their postpartum care independently. The availability of certain devices and hemostatic agents at retail pharmacies enables mothers to access essential supplies conveniently, contributing to timely and effective management of postpartum complications. As awareness regarding postpartum hemorrhage increases, retail pharmacies are expanding their offerings to include a range of treatment devices. This accessibility not only empowers mothers to take an active role in their recovery but also reinforces the overall market growth. Collaboration with healthcare providers to ensure that mothers receive proper guidance on the use of these devices further strengthens the role of retail pharmacies in this market.

Online Stores:

Online stores have revolutionized the distribution of postpartum hemorrhage treatment devices, providing an alternative platform for mothers to purchase essential medical supplies. The convenience of online shopping, alongside the broader range of products available, appeals to consumers looking for specific devices from the comfort of their homes. The increasing trend towards e-commerce is facilitating the growth of this segment, as more mothers turn to online platforms for their postpartum healthcare needs. Additionally, online stores often provide useful information, including reviews and recommendations, which can assist consumers in making informed purchase decisions. As internet penetration continues to rise globally, the online distribution of postpartum hemorrhage treatment devices is expected to experience significant growth in the coming years.

Others:

This segment includes various alternative distribution channels that contribute to the postpartum hemorrhage treatment device market. These channels may encompass specialized medical supply companies, direct-to-consumer sales, and other unique retail formats. The diversity of distribution channels enables greater accessibility to postpartum hemorrhage treatment devices, thereby enhancing the market's overall reach. Companies are increasingly exploring innovative distribution strategies to connect with healthcare providers and consumers, ensuring that the necessary devices are available when needed. The flexibility offered by these alternative channels allows for a responsive supply chain, catering to the varying demands of healthcare settings and patients alike. As the market continues to evolve, the role of these distribution channels is expected to grow, facilitating improved access to essential postpartum care solutions.

By Technology

Mechanical Devices:

Mechanical devices used in postpartum hemorrhage management are instrumental in providing effective treatment solutions. This category includes various devices designed to mechanically control or manage bleeding during and after childbirth. The growing acceptance of mechanical solutions among healthcare providers, due to their ease of use and effectiveness, is driving demand for this technology. Mechanical devices often require minimal training for healthcare professionals, making them an attractive option in busy healthcare environments. As the focus on improving maternal health outcomes intensifies, the adoption of mechanical devices in routine clinical practice is likely to increase, thereby contributing to the overall growth of the postpartum hemorrhage treatment device market.

Balloon Tamponade:

Balloon tamponade technology is a highly effective method for managing postpartum hemorrhage, utilizing inflatable balloons to exert pressure on the uterine wall. This approach is particularly beneficial in cases of uterine atony, as it offers a non-surgical intervention to control bleeding. The growing body of evidence supporting the efficacy of balloon tamponade in reducing blood loss is leading to its increased adoption in healthcare settings. Moreover, advancements in balloon technology have enhanced their usability, allowing for a quicker response time in emergency situations. As maternal health initiatives prioritize effective hemorrhage management, the demand for balloon tamponade technology is expected to rise significantly in the coming years.

Others:

The 'Others' segment encompasses various innovative technologies that contribute to postpartum hemorrhage management, including emerging devices and solutions not categorized under traditional classifications. This includes novel approaches tailored to address specific challenges associated with postpartum hemorrhage, such as advanced suturing techniques and new-generation hemostatic agents. The continuous evolution of technologies in maternal healthcare is creating opportunities for the introduction of cutting-edge solutions that enhance treatment outcomes. As research and development efforts in this area advance, it is anticipated that additional technologies will enter the market, enriching the postpartum hemorrhage treatment device landscape and further supporting market growth.

By Region

North America holds the largest share of the postpartum hemorrhage treatment device market, accounting for approximately 40% of the global market revenue. The region's dominance can be attributed to the presence of advanced healthcare infrastructure, high healthcare expenditure, and a robust focus on maternal health. Moreover, the increasing prevalence of cesarean deliveries coupled with high awareness levels regarding postpartum complications is propelling the demand for effective treatment devices. The CAGR for North America is projected to be around 6.5%, reflecting the ongoing investment in maternal healthcare initiatives and innovations within the region. Hospitals and maternity centers in North America are increasingly adopting advanced technologies, further solidifying the region's leadership in the postpartum hemorrhage treatment device market.

Europe is also witnessing substantial growth in the postpartum hemorrhage treatment device market, primarily driven by a rising emphasis on maternal health and increasing birth rates in various countries. The region is expected to account for approximately 25% of the global market share, with a projected CAGR of 6.2% during the forecast period. The implementation of strategic health policies aimed at enhancing maternal care and reducing maternal mortality rates contributes to the growth of this market segment. Additionally, increasing collaboration between governments, healthcare providers, and organizations to promote awareness and access to postpartum hemorrhage treatment devices is expected to create significant opportunities for market players in Europe.

Opportunities

The postpartum hemorrhage treatment device market is rife with opportunities driven by the growing focus on maternal healthcare. The increasing prevalence of postpartum hemorrhage due to factors such as high-risk pregnancies, rising cesarean sections, and other complicating medical conditions necessitates the development of innovative and effective treatment solutions. As healthcare systems worldwide continue to prioritize maternal health, there will be a heightened demand for advanced postpartum hemorrhage treatment devices, thereby opening corridors for growth for market participants. Moreover, the integration of technology in healthcare, such as telemedicine and remote monitoring, presents new opportunities for companies to expand their product offerings into homecare settings, ensuring that mothers can efficiently manage their postpartum health outside traditional hospital environments.

Another significant opportunity lies in emerging markets, where healthcare infrastructure is rapidly developing, resulting in increased accessibility to maternal health services. As awareness levels rise in these regions, the demand for postpartum hemorrhage treatment devices is expected to surge, creating possibilities for companies to establish their presence and capture market share. Strategic partnerships with local healthcare providers and distribution networks could further enhance market penetration in these emerging economies. Additionally, ongoing research and technological advancements pave the way for the introduction of novel treatment devices that meet the unique needs of various populations, thereby fostering further growth within the postpartum hemorrhage treatment device market.

Threats

Despite the positive outlook for the postpartum hemorrhage treatment device market, there are several threats that could hinder growth. One major concern is the regulatory environment surrounding medical devices, which can be stringent and vary across different regions. Compliance with these regulations can incur significant costs and may delay the introduction of new products to the market, potentially affecting the competitiveness of companies operating within this space. Additionally, the presence of alternative treatment methods and devices may pose a challenge, as healthcare providers might opt for established solutions that they are familiar with rather than exploring newer innovations. This reluctance to adopt new technologies can slow market growth and limit the potential for new entrants into the postpartum hemorrhage treatment device market.

Moreover, economic factors such as budget cuts in healthcare spending can impact the availability of funds for purchasing advanced treatment devices. This could lead to healthcare facilities prioritizing cost-effectiveness over the quality of care, potentially affecting the demand for innovative postpartum hemorrhage treatment solutions. Lastly, the ongoing challenges posed by global events such as pandemics can disrupt supply chains and affect the availability of essential medical devices. Companies in the postpartum hemorrhage treatment device market must navigate these threats effectively to maintain their competitive edge and ensure continued growth.

Competitor Outlook

• Medtronic
• Boston Scientific Corporation
• Hologic, Inc.
• Cook Medical
• Teleflex Incorporated
• Johnson & Johnson
• Smith & Nephew
• Abbott Laboratories
• Stryker Corporation
• Terumo Corporation
• Ethicon, Inc. (a subsidiary of Johnson & Johnson)
• ConvaTec Group PLC
• Ferring Pharmaceuticals
• Merit Medical Systems, Inc.
• Zimmer Biomet Holdings, Inc.

The competitive landscape of the postpartum hemorrhage treatment device market is characterized by a mix of established players and emerging companies that are continuously innovating to meet the evolving needs of healthcare providers and patients. Major companies such as Medtronic and Boston Scientific Corporation are leveraging their extensive research and development capabilities to introduce cutting-edge products that enhance postpartum hemorrhage management. With their established brand reputation and wide distribution networks, these industry leaders are well-positioned to capture significant market share. Additionally, they are actively engaging in collaborations and partnerships to expand their product offerings and penetrate new markets, further solidifying their competitive advantage.

Emerging players in the postpartum hemorrhage treatment device market are also making their mark by introducing innovative solutions tailored to specific patient needs. For instance, companies focusing on targeted hemostatic agents and advanced mechanical devices are gaining attention for their ability to provide effective treatments with minimal invasiveness. These newcomers are often more agile and responsive to market demands, allowing them to quickly adapt to changing healthcare landscapes. Moreover, their focus on cost-effective solutions is appealing to healthcare providers looking to optimize budgets while still ensuring quality care. As a result, the competition within this market is intensifying, driving continuous improvements in product development and service delivery.

Key companies such as Cook Medical and Teleflex Incorporated are investing heavily in research and development to expand their product portfolios and enhance their technological capabilities. Their commitment to innovation is evident in the introduction of new devices and treatment methodologies that aim to improve patient outcomes. Furthermore, these companies are increasingly focusing on sustainability and environmental considerations in their product development processes, aligning with global health trends. As the postpartum hemorrhage treatment device market evolves, the competitive dynamics will continue to shift, with established companies and new entrants both playing vital roles in shaping the future of maternal healthcare.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smith & Nephew
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ConvaTec Group PLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Teleflex Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Ferring Pharmaceuticals
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Merit Medical Systems, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Zimmer Biomet Holdings, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ethicon, Inc. (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Postpartum Hemorrhage Treatment Device Market, By Technology
    • 6.1.1 Mechanical Devices
    • 6.1.2 Balloon Tamponade
    • 6.1.3 Others
  • 6.2 Postpartum Hemorrhage Treatment Device Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Maternity Centers
    • 6.2.3 Homecare Settings
  • 6.3 Postpartum Hemorrhage Treatment Device Market, By Product Type
    • 6.3.1 Uterine Balloon Tamponade
    • 6.3.2 Non-Pneumatic Anti-Shock Garments
    • 6.3.3 Hemostatic Agents
    • 6.3.4 Suturing Devices
    • 6.3.5 Others
  • 6.4 Postpartum Hemorrhage Treatment Device Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Stores
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Postpartum Hemorrhage Treatment Device Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Postpartum Hemorrhage Treatment Device market is categorized based on

By Product Type

• Uterine Balloon Tamponade
• Non-Pneumatic Anti-Shock Garments
• Hemostatic Agents
• Suturing Devices
• Others

By Application

• Hospitals
• Maternity Centers
• Homecare Settings

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Stores
• Others

By Technology

• Mechanical Devices
• Balloon Tamponade
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific Corporation
• Hologic, Inc.
• Cook Medical
• Teleflex Incorporated
• Johnson & Johnson
• Smith & Nephew
• Abbott Laboratories
• Stryker Corporation
• Terumo Corporation
• Ethicon, Inc. (a subsidiary of Johnson & Johnson)
• ConvaTec Group PLC
• Ferring Pharmaceuticals
• Merit Medical Systems, Inc.
• Zimmer Biomet Holdings, Inc.